CLINICAL_TRIALS
trial_result
· 2023-11-22
Clinical Trial Update: Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients [Phase 2]
Summary
Phase 2 trial evaluating efficacy and safety of JP-2266 in patients with Type 2 Diabetes Mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN